The impact of 3D models on positive surgical margins after robot-assisted radical prostatectomy.

Journal: World journal of urology
Published Date:

Abstract

PURPOSE: To evaluate the role of 3D models on positive surgical margin rate (PSM) rate in patients who underwent robot-assisted radical prostatectomy (RARP) compared to a no-3D control group. Secondarily, we evaluated the postoperative functional and oncological outcomes.

Authors

  • Enrico Checcucci
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Angela Pecoraro
    Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
  • Daniele Amparore
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Sabrina De Cillis
    Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.
  • Stefano Granato
    Department of Urology, University of Turin, 'San Luigi Gonzaga' Hospital, Orbassano, Turin, Italy.
  • Gabriele Volpi
    Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano (Turin), Italy.
  • Michele Sica
    Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano (Turin), Italy.
  • Paolo Verri
    Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano (Turin), Italy.
  • Alberto Piana
    Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.
  • Pietro Piazzolla
    Department of Management and Production Engineer, Politechnic University of Turin, Turin, Italy.
  • Matteo Manfredi
    Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano (Turin), Italy.
  • Enrico Vezzetti
    Department of Management and Production Engineer, Politechnic University of Turin, Turin, Italy.
  • Michele Di Dio
    Division of Urology, Department of Surgery, SS Annunziata Hospital, Cosenza, Italy.
  • Cristian Fiori
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.